Position in CDXS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$43,926
-$660 QoQ
Shares Held
26,950
-1.5% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GUGGENHEIM CAPITAL LLC holds $195,988,894 across 74 Biotechnology names. CDXS ranks #68 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
100,386 | $44,826,363 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
42,909 | $33,153,208 | |
| 3 | INSM |
INSMED Inc
|
80,021 | $13,085,033 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
37,114 | $12,279,909 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
91,463 | $5,734,729 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
68,749 | $4,443,247 | |
| 7 | INCY |
Incyte Corp
|
44,622 | $4,199,821 | |
| 8 | EXEL |
Exelixis, Inc.
|
91,477 | $3,923,448 |
All Filings in CDXS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $43,926 | 26,950 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $44,586 | 27,355 | Shares | Defined | 2026-02-17 | |
| 2021-06-30 | $409,171 | 18,057 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $488,701 | 21,350 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $472,968 | 21,666 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $259,125 | 22,072 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $258,609 | 22,685 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $260,039 | 23,301 | Shares | Defined | 2020-06-02 | |
| No filing history on record for this holder in this stock. | ||||||